Cyndi Serrano: A Welcome Milestone in the Fight Against Underdiagnosed Iron Deficiency
Cyndi Serrano, Talent Operations Specialist at Wintrust Financial Corporation, reposted from Hemophilia Federation of America on LinkedIn:
”Really encouraged to see this milestone recommendation!
Iron deficiency is incredibly common, yet still underdiagnosed and undertreated.
This is exactly why early prevention and ongoing management matter so much—catching it early can make a huge difference in people’s daily lives and long-term health.
Great to see momentum building in this space.”
Quoting Hemophilia Federation of America‘s post:
”New Medical Guidance for the Bleeding Disorders Community
Iron deficiency can affect overall health, energy levels, and quality of life, yet it often goes undetected.
MASAC has released its first-ever recommendations for routine iron screening in people with bleeding disorders, offering important guidance for patients, caregivers, and healthcare providers.
Read HFA’s summary of the recommendations and learn why routine iron screening may play an important role in comprehensive bleeding disorders care.”

Stay updated with Hemostasis Today.
-
Sep 22, 2026, 13:58Giulia Passaniti: Dual Inferior Vena Cava Anatomy in Tetralogy of Fallot
-
Sep 22, 2026, 13:35Michael Miyamoto: Scaling Guideline Based Lipid Management in Community Practice
-
Sep 22, 2026, 13:15Suvro Sankha Datta: Developing Blood Group Genotyping Platform Using a Gold-Oligo
-
Sep 22, 2026, 13:07Caitlin Raymond: The Plasma Chaser in Therapeutic Plasma Exchange
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity